We have studied the distribution and sorption behavior of phosphate and arsenate in bed-sediments of the Anllóns river (NW Spain). As a consequence of the intense gold-mining activity in the past, substantial amounts of arsenic were found in the river sediments. For phosphorus, higher concentrations were found near two sources of P pollution. Sorption isotherms were described by the Freundlich, Langmuir and Tempkin equations. In general, the sediments sorbed more P than As. The equilibrium P concentration (EPC) reveals that sediments act as a scavenger for soluble P; by contrast, equilibrium As concentration (EAC) values were high for the As-rich sediments and correlates well with total arsenic content. Amorphous Fe oxides content, organic matter and fraction of clay plus silt were the main properties of the sediments related with the sorption of arsenate and phosphate. The results obtained provide a first estimate of the sorption behavior and availability of the phosphate and arsenate anions in the sediments of the Anllóns river.
Liver dysfunction due to a low cardiac output state after cardiac surgery is associated with a poor prognosis, but whether one inotrope is superior to another in improving hepatic perfusion remains uncertain. This study compared the systemic and hepatic haemodynamic effects of levosimendan to dobutamine in patients with a low cardiac output state (cardiac index < 2.2 1/min/m2) after on-pump cardiac surgery. A total of 25 patients were randomised to receive either an intravenous bolus of levosimendan (12 μg/kg) over 15 minutes, followed by an infusion of 0.2 μg/kg/min for 24 hours, or an infusion of dobutamine 7.5 μg/kg/min for 24 hours and completed the study. The systemic and hepatic haemodynamics at 24 and 48 hours were all better after levosimendan than dobutamine (dobutamine group: cardiac index (1/min/m2)=2.51 [standard deviation ±0.29], 2.40±0.23; portal vein flow (ml/min): 614.0± 124.7, 585.9±144.8; pulsatility index: 2.02±0,28, 2.98±0.27 versus the levosimendan group: cardiac index: 3.02± 0.27, 2.98± 0.30; portal vein flow: 723.0± 143.5, 702.9±117.8; pulsatility index: 1.71 ±0.26,1.73 ±0.27). The improvement in portal vein blood flow at 48 hours was significantly better after levosimendan than dobutamine (41% vs. 11% increment from baseline, P<0.05). In addition, there was a significant reduction in hepatic artery resistance after levosimendan but not dobutamine (resistance index reduction 6.5% vs. 0%, P<0.05). In summary, levosimendan can be considered as a selective liver vasodilator and can improve hepatic blood flow through both the hepatic artery and portal venous system, whereas dobutamine can only improve the portal venous blood flow without vasodilating the hepatic artery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.